Community seroprevalence survey for yaws and trachoma in the Western Division of Fiji

scientific article

Community seroprevalence survey for yaws and trachoma in the Western Division of Fiji is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/TRSTMH/TRW069
P932PMC publication ID5155547
P698PubMed publication ID27852877

P50authorDavid MabeyQ37834883
Michael MarksQ42786147
Chrissy H RobertsQ56426648
Robert ButcherQ56781523
Naomi CocksQ64364636
Mike KamaQ78549817
Stephanie J MigchelsenQ83428337
Colin K. MacleodQ88123720
Chelsea YalenQ117278869
P2093author name stringApisalome Nakolinivalu
Merelesita Rainima-Qaniuci
P2860cites workTrachoma and Yaws: Common Ground?Q26775120
CT694 and pgp3 as serological tools for monitoring trachoma programsQ28484816
Serology for trachoma surveillance after cessation of mass drug administrationQ28543658
Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of FijiQ28596379
Electronic data capture tools for global health programs: evolution of LINKS, an Android-, web-based systemQ28660227
Endemic treponemal diseasesQ34172900
A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: rationale and target product profilesQ34364970
Global epidemiology of yaws: a systematic reviewQ34669935
A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, MaliQ34723495
Scabies and impetigo prevalence and risk factors in Fiji: a national surveyQ35148030
Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of YawsQ35737445
Serological Measures of Trachoma Transmission IntensityQ36387948
The development and validation of dried blood spots for external quality assurance of syphilis serologyQ36650928
The SAFE strategy for trachoma control: Using operational research for policy, planning and implementationQ37063682
Mapping Trachoma in the Solomon Islands: Results of Three Baseline Population-Based Prevalence Surveys Conducted with the Global Trachoma Mapping ProjectQ37835251
Prevalence of Chlamydia trachomatis infection in Samoan women aged 18 to 29 and assessment of possible risk factors: a community-based study.Q37841692
Chlamydia in the Pacific region, the silent epidemicQ37857163
The prevalence of sexually transmitted disease agents in pregnant women in SuvaQ37901362
Development of a new platform for neglected tropical disease surveillanceQ39158723
Correction: Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Naïve Trachoma-Endemic Region of the Solomon IslandsQ42388331
Use of mixture models in determining laboratory criterion for identification of seropositive individuals: application to parvovirus B19 serologyQ68453367
Eradication of yaws--the Morges strategyQ95491021
P433issue10
P921main subjectyawsQ76973
seroprevalenceQ3511357
FijiQ5425748
P304page(s)582-587
P577publication date2016-11-16
P1433published inTransactions of the Royal Society of Tropical Medicine and HygieneQ15766916
P1476titleCommunity seroprevalence survey for yaws and trachoma in the Western Division of Fiji
P478volume110

Reverse relations

cites work (P2860)
Q62898910A search for trachoma in Timor-Leste: no evidence to justify undertaking population-based prevalence surveys
Q59804310A systematic review of historical and contemporary evidence of trachoma endemicity in the Pacific Islands
Q62898898Absence of Serological Evidence of Exposure to Treponema pallidum among Children Suggests Yaws Is No Longer Endemic in Kiribati
Q56365896Advancing the public health applications of Chlamydia trachomatis serology
Q54943022Clinical signs of trachoma are prevalent among Solomon Islanders who have no persistent markers of prior infection with Chlamydia trachomatis.
Q52642699Community-based mass treatment with azithromycin for the elimination of yaws in Ghana-Results of a pilot study.
Q43924390Comparison of Platforms for Testing Antibody Responses against the Chlamydia trachomatis Antigen Pgp3.
Q56355704Comparison of three serological assays to measure antibody response to Chlamydia antigen Pgp3 in adolescent and young adults with pelvic inflammatory disease
Q89527701Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma
Q40045638Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati
Q43366299Serology reflects a decline in the prevalence of trachoma in two regions of The Gambia
Q60300335The utility of serology for elimination surveillance of trachoma

Search more.